EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Navigating risk in biological quality testing: A guide for emerging laboratories

Rashmi Shrivastava, Sanchi Goel, Niharika Trivedi, Neelima Mishra, Shalini Tewari

The Indian Journal of Medical Research · 16.05.2026 · 163 · 611-617

DOI: 10.25259/ijmr_3513_2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 16.05.2026. Verfasst von Rashmi Shrivastava und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quality Management Unit, National Institute of Biologicals, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Quality Control, Laboratories, Biological Products. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological products are inherently complex and highly sensitive to variations in testing conditions, rendering quality control (QC) testing laboratories particularly vulnerable to high-impact operational, analytical, and biosafety risks. Despite the emphasis on risk-based thinking in international standards, a structured laboratory-specific framework for identifying, assessing, and mitigating risks in biological product QC testing remains insufficiently articulated. This article presents a simplified approach for proactive identification of testing-related and occupational health risks, along with their mitigation and conversion into opportunities. The concept aligns with internationally accepted standards, including ISO/IEC Guide 51, ISO 31000:2018, ISO/IEC 17025:2017, and ICH Q9 guidelines. Implementation of this framework enhances the reliability of results, strengthens regulatory compliance, and improves patient and occupational safety. By addressing the gap in structured risk assessment for biological QC laboratories, the article provides practical guidance for implementing ISO/IEC 17025:2017 Clause 8.5 and enables continuous improvement through systematically converting identified risks into opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality ControlLaboratoriesBiological ProductsHumansRisk Assessment

Stichwörter der Autor:innen

Biological productsICH Q9ISO/IEC 17025Quality control laboratoriesRisk assessmentRisk priority number

Substanzen

Biological Products

Autor:innen und Institutionen

  • Quality Management Unit, National Institute of Biologicals, Noida, Uttar Pradesh, India.

Zitieren

APA

Shrivastava, R., Goel, S., Trivedi, N., Mishra, N., & Tewari, S. (2026). Navigating risk in biological quality testing: A guide for emerging laboratories. The Indian Journal of Medical Research, 163, 611-617. https://doi.org/10.25259/ijmr_3513_2025

Vancouver

Shrivastava R, Goel S, Trivedi N, Mishra N, Tewari S. Navigating risk in biological quality testing: A guide for emerging laboratories. The Indian Journal of Medical Research. 2026;163:611-617. doi:10.25259/ijmr_3513_2025

BibTeX
@article{Shrivastava2026,
  author = {Shrivastava, Rashmi and Goel, Sanchi and Trivedi, Niharika and Mishra, Neelima and Tewari, Shalini},
  title = {Navigating risk in biological quality testing: A guide for emerging laboratories},
  journal = {The Indian Journal of Medical Research},
  year = {2026},
  volume = {163},
  pages = {611--617},
  doi = {10.25259/ijmr_3513_2025}
}
Kostenlos starten →